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Highlights 
 CDs : (RS) and (SS)-SFN and analogues inclusion complexes were determined by NMR. 
 -CD has the highest affinity for SFN and its analogues 
 Aqueous stability of SFN and analogues is improved in -CD  
 -CD is able to discriminate between the two enantiomers of SFN and SFN 
homologues. 
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ABSTRACT. Sulforaphane (SFN), a phytochemical isolated from broccoli is an 
important antitumoral compound with additional beneficial effect on other important 
diseases However, the chemical instability of SFN has hampered its clinical use. In 
order to circumvent this problem, we report the first comparative study on the inclusion 
complexes of SFN and SFN homologues with different cyclodextrin by NMR 
spectroscopy. From this study it has been shown that -CD is most indicated 
cyclodextrin for the stabilization of SFN and SFN homologues, and that the highest 
affinity constant is that of the isothiocyanate obtained from the wasabi. Furthermore, the 
study of the inclusion complexes of -CD and the non-natural SFN and analogues with 
S absolute configuration at sulfur shows for the first time that -CD is able to 
discriminate between the two enantiomers, with the natural R enantiomers forming the 
inclusion complexes with higher affinity.  
Keywords: Sulforaphane, Sulforaphane analogues, Sulforaphane stabilty, 
Cyclodextrins, Chiral discrimination, Affinity constants. 
 
 INTRODUCTION 
Considered by the FDA as one of the most significant anticancer products, 
sulforaphane (RS-1-isothiocyanato-4-(methylsulfinyl)butane) a phytochemical 
product, (Lenzi, Fimognari, & Hrelia, 2014) has received increasing attention in 
recent years (Zhang, Talay, Cho, & Posner, 1992). Isolated in 1992 from 
broccoli, it was immediately proved to be the most effective inducer of the so-
called phase-2 cytoprotective, antioxidant/detoxification system (Dinkova-
Kostova, & Talalay, 2008), itself regulated by the Keap1/Nrf2 pathway/Are 
pathway (Kensler et al., 2013). Sulforaphane belongs to a family of 
phytochemicals, containing an isothiocyante group, present in large quantities in 
cruciferous such as broccoli, cauliflower, watercress, Brussels sprouts, and 
cabbage. These organic isothiocyanates are present in the plants in the form of 
their biologically inactive precursors, the glucosinolates (Grubb, & Abel, 2006). 
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These inactive precursors are converted to their cognate, biologically active 
isothiocyanate, by the enzymatic action of myrosinase upon mastication of the 
plant tissue by humans, pathogens, and predators and upon food preparation 
(Kliebenstein, Kroymann, & Olds, 2005). Myrosinase, a thioglycosidase 
catalyses the hydrolysis of the thioglycosidic bond of the glucosinolates such as 
glucopharanin 1, leading to unstable intermediates, which at physiological pH, 
predominantly undergo Lossen rearrangements to the corresponding 
isothiocyanate, such as 2 (Kliebenstein, Kroymann, & Olds, 2005).  
 
Scheme 1: Biosynthetic pathway to (RS)-sulforaphane 2: Lossen rearrangement 
through myrosinase deglycosylation of glycopharin 1. 
 Animal studies on rats have established the chemopreventive activity of 
sulforaphane (SFN) against colon cancer (Chung, Conaway, Rao, & Reddy, 
2000; Gamet-Payrastre et al., 2000), and in women at risk for breast cancer 
(Comblatt et al., 2007). In addition to increasing cellular capacity for detoxifying 
electrophiles and oxidants, SFN has been shown to induce apoptosis, and to 
inhibit cell cycle progression and angiogenesis (Clarke, Dashwood, & Ho, 2008; 
Juge, Mithen, & Traka, 2007; Singh et al., 2009). Further, SFN can cross the 
blood-brain barrier and can exert its protective effects in the central nervous 
system (Carrasco-Pozo, & Borges, 2015; Kim et al., 2016; Tozzi et al., 2013). It 
has potent and selective antibiotic activity, in particular, against Helicobacter 
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pylori, a risk for gastric cancer (Fahey et al., 2002; Yanaka et al., 2009). SFN has 
also been shown to induce anti-proliferative effects via epigenetic mechanisms 
(Tortorella, Royce, Licciardi, & Karagiannis, 2015), namely acting as dietary 
histone deacetylase inhibitor through its metabolite SFN-cysteine (Clarke, Hsu, 
Yu, Dashwood, & Ho, 2011; Meeran, Patel, & Tollefsbol, 2010; Xu, Parmigiani, 
& Marks, 2007), and to suppress DNA methylation (Hsu et al., 2011). More 
recently, it has also been shown that SFN serve for the treatment of autism 
spectrum disorder (Singh, et al., 2014), and enhances progerin clearance in 
Hutchinson–Gilford progeria fibroblasts (Gabriel, Roedl, Gordon, & Djabali, 
2015).  
Based on these data, it is therefore not surprising that there is currently a great 
interest in the use of sulforaphane in the clinic and as food supplement 
(Houghton, Fasset, & Coombes, 2013). However, up to now there is no marketed 
drug with sulforaphane, being the entire SFN-related market based on broccoli 
extracts, anti-aging creams, diet concentrates and other herbal products. In this 
sense, it should be pointed out that broccoli supplements normally contain 
glucopharanin, but not myirosinase, which makes questionable their ability to 
provide sulforaphane, since although the glucopharanin can be converted to SFN 
by microbiota (Bheemreddy, & Jeffery, 2007), the bioavailability of SFN in this 
case is six times lower than when the conversion to SFN is prior to ingestion 
(Shapiro, Fahey, Wade, Stephenson, & Talalay, 2001). However, several clinical 
trials are being carried out to treat different pathologies including prostate and 
breast cancer, autism (both in phase II), schizophrenia, or diabetes type 2 among 
others (https://clinicaltrials.gov/ct2/results?term=Sulforaphane&Search=Search, 
1st of June 2017). One of the main reasons that no pharmaceutical preparation 
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applicable to any particular disease is currently commercialized is the instability 
of the SFN molecule, since it is susceptible to degradation by the action of 
oxygen, heat and even at physiological conditions, consequence of its chemical 
structure (Jin, Wang, Rosen, & Ho, 1999). SFN is a small molecule with two 
reactive functional groups, a dialkyl sulfoxide and an isothiocyante. At high 
temperature, the sulfoxide group undergoes a syn -elimination affording butenyl 
isothiocyanate and methyl sulfenic acid, a transient molecule, which evolve to 
other volatile sulfur derivatives (Cubbage, Guo, McCulla, & Jenks, 2001). The 
high reactivity of the isothiocyanate group, which is at the basis of its biological 
activity, is also responsible of its degradation in water and in biological media 
leading to non-volatile, inactive organic compounds (Dubuois, Marchal, Lacroix, 
& Cabou, 2012).    
Thus, beside the active research carried out to find chemically stable and 
biologically more active analogues, there is a great interest in developing 
effective ways to stabilize natural sulforaphane in particular and natural 
isothiocyanates in general. Two approximations have been reported, using either 
cyclodextrins (Dagan, Frisbee, Newsome, & Baudet, 2011; Fahey et al., 2017), 
mainly hydroxpropyl cyclodextrin (Wu, Liang, Yuan, Wang, & Yan, 2010; Wu, 
Mao, Mei, & Liu, 2013), or spray dry microencapsulation into maltodextrin (Wu, 
Zou, Mao, Huang, & Liu, 2014).  
Cyclodextrins (CDs) are macrocyclic oligosaccharides obtained from the 
enzymatic degradation of starch, composed by α-D-glucopyranose units (α-1→4)-linked 
(Szejtli, 1998). The most relevant members of this family are constituted by 6, 7 and 8 
units of glucose, denominated -, - and -CD, respectively, Figure 1. They have 
truncated cone geometry, with the secondary hydroxyls (OH-2 and OH-3) at the wider 
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edge of the cone and the primary hydroxyls (OH-6) of the sugar residues at the narrow 
edge. The skeletal carbons, the ethereal oxygens and the H-3 and H-5 protons, form the 
internal cavity, which gives it a hydrophobic character. This unique structure makes 
CDs behave like water-soluble nanocontainers for hydrophobic substances of 
appropriate size. Additionally, CDs are biocompatible, do not elicit immune response, 
and have low toxicities in animals and humans. Thus, since Freudenberg registered the 
first patent on the use of CDs in the formulation of drugs (Freudenberg, Cramer, & 
Plieninger, 1953), their properties have found many applications in pharmaceutical, 
cosmetic, agrochemical and food industry, among others (Davis, & Brewster, 2004). 
From a more fundamental perspective, cyclodextrins have found application in the 
design of molecular machines (Wenz, Han, & Muller, 2006), nanoparticles (Mejia-
Ariza, Graña-Suárez, Verboom, & Huskens, 2017), catalysts (Vriezema et al., 2005) or 
artificial enzymes (Villalonga, Cao, & Fragoso, 2007). The molecular inclusion 
properties of the CDs have been exploited, for example, to improve the bioavailability 
of poorly soluble drugs and to protect the active molecule from degradation processes or 
prevent it from reacting with other components. Additionally, some unpleasant side 
effects, such as tissue irritation, bad taste or bad odour, can also be avoided by using 
CDs as transporters. Surprisingly, CDs have been scarcely used in the formulation of 
sulfinyl isothiocyanates, with only a patent work disclosing the use of -CD (Dagan, D, 
Frisbee, Newsome, & Baudet, 2011) which has recently been included in a preclinical 
study (Fahey, et al., 2017) and two papers using the second-generation HP--CD.  
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Figure 1. Size of the internal cavities of ,  and -Cyclodextrins 
However, there is no data on the strength of the inclusion complexes of SFN 
with cyclodextrins, that due to their different size cavities, Figure 1, one expects 
that they could have different association constants. Additionally, for a given 
cyclodextrin the association constant may be different for each of the SFN 
enantiomers, used usually in racemic form in a number of studies.  
Based on these premises, and within our interest in the asymmetric synthesis of 
SFN analogues (Elhalem et al.,2014; Khiar et al., 2009; Khiar, Fernández, & 
Recio, 2013), in the present work we report a comparative study of the inclusion 
of RS-1-isothiocyanato-6-(methylsulfinyl)hexane 4-RS, an isothiocyanate found in 
the wasabi with -, -, and hydroxypropyl--cyclodextrin, Figure 1. A 
comparative study for the inclusion of each enantiomer of sulforaphane 2 (2R and 
2S), and each enantiomer of its homologues 1-isothiocyanato-5-
(methylsulfinyl)pentane 3 (3R and 3S), and 1-isothiocyanato-6-
(methylsulfinyl)hexane (4R and 4S) with -cyclodextrin, revealed for the first an 
interesting chiral discrimination phenomena, Figure 2. We also report a 
degradation study of the SFN analogues in aqueous solution, over time, at room 
temperature in the presence and absence of cyclodextrins. 
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Figure 2. Structure of both enantiomers of sulforaphane (2-RS, 2-SS) and 
homologues (3-RS, 3-SS, 4-RS, and 4-SS) used in this study to form inclusion 
complexes with cyclodextrins. The acronym lp stands for electron lone pair. 
 RESULTS AND DISCUSSIONS 
We have recently reported an enantiodivergent approach for the synthesis of both 
enantiomers of sulforaphane and sulforaphane homologues with different chain length 
between the sulfinyl sulfur and the isothiocyanate groups and different substituents on 
the sulfinyl sulfur, Scheme 1 (Khiar et al., 2009). 
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Scheme 2: Enantiodivergent synthesis of both enantiomers of sulforaphane 2-RS/2-SS 
and homologues 3-RS/3-SS and 4-RS/4-SS: a) CH3MgBr, toluene b) (i) PPh3, Et2O, 
reflux, (ii) CS2, reflux. 
The key step of the approach is the diastereoselective synthesis of both sulfinate 
esters epimer at sulfur (8-RS, 9-RS, 10-RS, and 8-SS, 9-SS, 10-SS) from racemic sulfinyl 
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chloride 5-7 using as single chiral auxiliary the sugar derived diacetone-D-glucose 
(DAGOH) (Fernández & Khiar, 2003), by a simple change of the achiral base used to 
catalyse the reaction (Fernández & Khiar, 2003). Condensation of methyl magnesium 
bromide on the sulfinate esters, followed by a two-step one pot approach consisting of a 
Staudinger reaction with triphenylphosphine and subsequent aza Wittig-type 
condensation of the resulting iminophopsphorane with carbon disulphide. Following 
this approximation, both enantiomers of sulforaphane (2-RS and 2-RS), 1-
isothiocyanato-5-(methylsulfinyl)pentane (3-RS and 3-RS), and 1-isothiocyanato-6-
(methylsulfinyl)hexane (4-RS and 4-RS) found in Japanese horseradish, wasabi (Wasabia 
japonica) (Morimitsu, et al., 2002), were obtained in good chemical yield and in 
enantiopure forms.  
Among the different methods used for the study weak and moderate strength inclusion 
complexes (Thordarson, 2011), NMR spectroscopy is well suited as both guest and host 
molecules can be simultaneously observed at the atomic level (Fielding, 2000). The 
success of NMR spectroscopy in this field is due to its ability to study complex 
chemical systems, to determine complex stoichiometry, association constants, and 
conformations and to obtain information on their symmetry and dynamics. Since the 
rates of complex formation and decomposition are usually faster than the chemical shift 
time scale (often misleadingly named NMR time scale), the observed chemical shifts 
are the mole fraction weighted averages of the chemical shifts existing in the free and 
complexed molecules (Schneider, Hacket, Rüdiger, & Takeda, 1998).  
 Thus, the formation of the inclusion complexes of SFN and SFN-analogues used 
as guests with CDs used as hosts, their stoichiometry, association constants (Ka) and 
degree of degradation have been determined by NMR spectroscopy. In a first place and 
in order to determine the best cyclodextrin for the inclusion of SFN and SFN analogues, 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 10 
we used RS-1-isothiocyanato-6-(methylsulfinyl)hexane 4-RS as guest and -, -, and 
HP-CD as hosts. After assigning all the protons of the compounds using homonuclear 
1D and 2D NMR experiments, Figure 3A, we carried out the titration experiments. In 
the case of CD, we prepared 15 assays in which the concentration of the guest was 
maintained constant, while the concentration of the host was increased from 0 mM to 
9.93 mM, Figure 3C. A down-field shift was observed for the resonances of all the three 
groups of protons used as diagnostic signals for the titration. These resonances shift 
from 1.6653 ppm in the absence of CD to 1.7419 ppm at a maximum CD concentration 
(9.93 mM) in the case of the two protons belonging to the C5 (CH2CH2CH2), from 
2.8192 to 2.8572 ppm for the methylene in α to the sulfinyl group (CH2S) and from 
2.6276 to 2.6611 ppm for the three protons of the methylsulfinyl group (SCH3), Figure 
3C. The registered variation of the chemical shifts between the complexed and free 
guest for three types of protons, Figure 1B, was plotted against an increasing 
concentration of the host, and allowed the determination of the association constant of 
the inclusion complex using iterative least squares fitting procedure on the basis of a 1:1 
stoichiometry model. The excellent fitting obtained was supportive of the stoichiometry 
of the inclusion complex, and allowed us to determine the association constant (Ka). As 
is usual with the experimental measurements, three different values have been obtained 
for the Ka, being the value calculated with the CH2S chemical shift data significantly 
higher (504 M-1) than the other two (with an approximate value of 200 M-1). It was 
assumed that the CH2S protons, the ones experiencing the shortest shift and therefore 
least sensitive to molecular inclusion, may be affected by some other factor that distorts 
the measurement, so we consider the average value of the other two constants, whose 
values are relatively close. Therefore the value of Ka at equilibrium for the complex 
formed by 4-RS and β-CD is 192 ± 53 M-1 (Table 1, entry 1). Regardless of the 
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dispersion of the calculated constants, which is not uncommon with CDs (Connors, 
1997; Rekharsky & Inoue, 1998), the value of Ka is moderate, probably because the 
cavity of the βCD is too large in comparison with the size of the guest to induce a tight 
fitting. For this reason, we performed the following tests with other cyclodextrins, α-CD 
and HP-β-CD, to find the best coupling between host and guest. 
 
Figure 3. 1HNMR titration experiments of RS-1-isothiocyanato-6-
(methylsulfinyl)hexane 4-RS with - and -CDs: (A) 1HNMR spectra of pure 4-RS. (B) 
Chemical shift changes of reporters protons upon adding increasing amount of -CD 
host. (C) Portion of 1HNMR spectra of 4-RS alone and in the presence of 9.37 mM of -
CD. (D) Portion of the 1HNMR spectra of 4-RS alone and in the presence of 11.99 mM 
of HP--CD 
 In this case, beside the three groups of protons used in the titration of CD and 
RS-6HITC, we have also registered the chemical shift variation of the two protons 
corresponding to the carbon attached directly to the isothiocyanate group (CH2NCS), 
Figure 3D. Following the same approximation than before, in the case of HP-β-CD we 
have had discordance with only one of the signals corresponding to the protons of a 
central methylene group in the aliphatic chain, which has resulted in a Ka significantly 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 12 
inferior to the rest, therefore, we have not taken it into account. The calculated value of 
the Ka (Table 1, entry 2) is 135 ± 24.8 M
-1, indicating that the interaction between HP-β-
CD and the 4-RS analogue is weaker than in the case of βCD. However, the analysis of 
the complexation properties of α-CD towards the same guest 4-RS presents some 
significant differences with respect to the other cyclodextrins. While the obtained values 
are also compatible with the existence of a complex with a 1:1 stoichiometry, the 
association constant Ka is significantly higher. In this case, the calculated association 
constant Ka (Table 1, entry 3) is 1560 ± 105 M
-1, that is 8 times larger than that obtained 
with β-CD, and more than one order of magnitude than that of HP-β-CD the most 
widely used cyclodextrin for the stabilization of SFN. Based on this result, which 
highlights the complementarity of the smaller size cavity of α-CD to host the SFN 
analogue 4-RS, we conducted a study in order to unravel its affinity to others 
isothiocyanates including sulforaphane and, most importantly, to study the chiral 
discrimination between both enantiomers of each isothiocyanate, if there is any. In the 
case of natural sulforaphane (RS-1-isothiocyanato-4-(methylsulfinyl)butane) 2-RS, the 
titration has been carried out using the chemical shift change of the methylsulfinyl 
group, and three methylene groups of the internal aliphatic chain (CH2  to the sulfinyl, 
CH2  and  to the isothiocyanate group, see supporting information). In this case, the 
four association constants obtained were in the same range (463 M-1 for CH2  to the 
isothiocyanate, 526 M-1 for CH2  to the isothiocyanate, 533 M-1 for CH2  to the 
sulfoxide group, and 611 M-1 for the methyl group), the average value being 519 ± 55.8 
(Table 1, entry 5), a value lower than that of 4-RS (RS-1-isothiocyanato-6-
(methylsulfinyl)hexane). In the case of the analogue RS-1-isothiocyanato-5-
(methylsulfinyl)pentane 3-RS, the titration has been carried out using the chemical shift 
change of the methyl sulfinyl group, and four methylene groups of the internal aliphatic 
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chain (CH2  and  to the sulfinyl, and the CH2  and  to the isothiocyanate group, see 
supporting information).  In this case, the association constants measured for each of the 
five proton signals were also in the same range (1180 M-1 for CH2  to the 
isothiocyanate, 1130 M-1 for CH2  to the isothiocyanate, 1250 M-1 for CH2  to the 
sulfoxide group, 1260 M-1 for CH2  to the sulfoxide group and 1660 M-1 for the methyl 
group), the average value being 1229 ± 127 M-1, a value lower than that of 4-RS, and 
higher than that of natural sulforaphane. The results obtained so far indicate a clear 
relationship between the length of the aliphatic chain and the affinity towards -
cyclodextrin. The highest affinity constant’s being that of the compound with the 
longest aliphatic chain between the sulfinyl and isothiocyanate groups, ie 4-RS (RS-1-
isothiocyanato-6-(methylsulfinyl)hexane). 
Table 1. Association constants of both enantiomers of sulforaphane 2-RS/2-SS and 
homologues 3-RS/3-SS and 4-RS/4-SS. 
Entry Compound Cyclodextrin Association 
Constant (M-1) 
 
1 
SCN
S
O
 
4-RS 
 
HP--CD 
 
135 ± 25  
 
2 
SCN
S
O
 
4-RS 
 
-CD 
 
 
192 ± 53  
 
3 
SCN
S
O
 
4-RS 
 
-CD 
 
 
1560 ± 105 
 
4 
SCN
S
O
 
4-SS 
 
-CD 
 
 
887 ± 203 
 
5 
SCN
S
O
 
2-RS 

-CD 

 
519 ± 56  
 
6 
SCN
S
O
 
2-SS 

-CD 
 
 
176 ± 36  
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7 SCN S
O
 
3-RS 

-CD 
 
 
1229 ± 127 
 
8 SCN S
O
 
3-SS 

-CD 
 
 
715 ± 132  
 
These results encourage us to undergo a study on the chiral discrimination of -CD 
between the two enantiomers of a given sulfinylisothiocyanate molecule. In this sense, 
due to the presence of D-glucose units, CDs are chiral molecules and as such can form 
disatereoisomers with other molecules having a chiral centre. The capacity of -
cyclodextrin to discriminate between two enantiomers of a chiral guest was firstly 
reported in the late fifties of the last century (Cramer & Dietsche, 1959). The discovery 
of the crucial importance of chirality on the biological activity of drugs has deeply 
changes the legislation on their commercialization by the drug agencies worldwide 
(Nguyen, He, & Pham-Huy, 2006). Thus, the preparation and characterization of single 
enantiomers has been a standing area of interest in the last three decades (Borman, 
2001). In this sense, CDs have been widely studied in chiral resolution of racemates 
(Kano, 1997), as chiral reactors for enantioselective transformations (Macaev, & 
Boldescu, 2015) and in chiral discrimination of enantiomers in solution (Shahgaldian & 
Pieles, 2006).  Thus, our next objective was the study of the inclusion complexes of -
CD and the non-natural SFN and analogues, in order to determine the possible ability of 
-CD to discriminate between (R) and (S)-enantiomers of SFN and SFN analogues 
guests. This study is important taking into account the future evolution of sulforaphane 
and sulforaphane analogues market. In this sense, most of the medical applications 
either use broccoli extract rich of SFN that is the (R)-enantiomer, while others use 
racemic mixture obtained from non-asymmetric synthesis. For industrial production of 
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SFN, it is predicted that the racemic mixture will be preferred, consequence of the low 
cost of non-enantioselective chemical synthesis.  
 Following the same approximation used for the determination of the affinity 
constants explained before we determine the association constants of -CD with the (S)-
enantiomer of SFN 2-SS, with SS-1-isothiocyanato-6-(methylsulfinyl)hexane 4-SS, and 
with SS-1-isothiocyanato-5-(methylsulfinyl)pentane 3-SS. In the case of the non natural 
(S)-SFN 2-SS, the average of 4 association constants, obtained through the titration of 
the methylsulfinyl group, and three methylene groups of the internal aliphatic chain, 
gave a value of 176 ± 36 M-1. Taking into account that the association constant of -CD 
and natural SFN is 519 ± 56 M-1, quasi three times higher than that with the (S)-
enantiomer, we can conclude that there is an important chiral discrimination between 
the two enantiomers of sulforaphane by -CD. The same trend has been obtained with 
3-SS and 4-SS analogues. The average values obtained for the former is 715 ± 132 M
-1 
(Table 1, entry 8) and 887 ± 203 M-1 (Table 1, entry 4) for the later, quasi twice lower 
than those obtained with the corresponding 3-RS and 4-RS respectively. These results 
indicate that the chiral discrimination of -CD between the two enantiomers of sulfinyl-
alkane-isothiocyanates is general, being the inclusion complex with the natural (R)-
enantiomer the most favoured one. The magnitude of the chemical shift changes in the 
inclusion complexes of -CD for each of the enantiomers, allows the determination of 
the topology of the supramolecular complexes. In this sense, analyses of the six 
inclusion complexes show that the methylene groups of the aliphatic chain, between the 
two functionalities are all affected, but at different extents. The major chemical shift 
difference is observed for the methylene  to the sulfinyl group, and the minor one is the 
methylene - to the sulfoxide. The methylene nears the isothiocyanate are also affected 
by the cyclodextrin effect, but at a lesser extent than the central ones. At the contrary, 
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the chemical shift difference of methyl substituent of the sulfinyl sulfur, is practically 
the same in the inclusion complex than in the free compounds. All these data indicate 
that the inclusion of SFN and analogues consists in the incorporation of the aliphatic 
chain and the isothiocyanate moiety into the -CD cavity. The resulting complex can be 
further stabilized by hydrogen bonding between the basic sufinyl oxygen and the 
secondary hydroxy groups situated at the wider edge of truncated cone-shaped 
cyclodextrin. The observed stereospecificity of inclusion of SFN and SFN analogues 
into -CD, can thus be explained by the interaction between the methyl substituent of 
the sulfoxide group and the cyclodextrin substituent, favouring the enantiomers with the 
R absolute configuration at the sulfinyl sulfur, Figure 4. 
 
Figure 4. Explanative model for the observed inclusion stereospecificity of sulfinyl 
isothiocyanate into -CD. 
The proposed model, can adequately explain the reported stabilization of cyclodextrin. 
Indeed, as it was indicated before, the high aqueous instability of sulforaphane is a 
consequence of the high reactivity of the isothiocyanate group, which in presence of 
water leads to the free amine, followed by reaction of the amine with an isothiocyanate 
of other molecules affording the dimeric thiourea compound. In the inclusion complex 
the isothiocyanate group is incorporated into the hydrophobic cavity of the cyclodextrin 
and is thus less accessible to the water molecules.  Based on this assumption we 
O 
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conducted a comparative stability study of 4-RS (RS-1-isothiocyanato-6-
(methylsulfinyl)hexane) in aqueous solution at room temperature in the absence, Figure 
4 and in the presence of HP--CD and -CD, Figure 5.  
 
Figure 5. Section of the 1H NMR spectra of 4-RS (500 MHz, 3 mM, D2O) at (A) time 0 
and (B) after 4.5 months at room temperature. The inbox highlights the CH3 signal 
splitting upon degradation, which is quantified on the basis of the decrease of intensity 
of CH2NCS resonance (3.5 ppm) vs. CH3 signal (2.6 ppm) in ca. 50%.  
 The study has bee conducted on a 3 mM solution of the SFN analogue 4-RS in 
D2O, followed by recording successive 
1H NMR spectra at different time lapses. 
Degradation was monitored by the decrease of relative intensity of CH2NCS resonance 
and CH3S splitting. At time 0 (Figure 4A) signals appear as triplet and singlet, 
respectively, with the expected 2/3-relative intensity. Successive experiments revealed 
the decrease of CH2NCS resonance intensity (ca. 50% in 4.5 months at rt, Figure 4B) 
and the parallel splitting of CH3S signal. In parallel, two other aliquots of the starting 4-
RS solution were added α- or HPβCD to a 4-RS:CD molar ratio of 1:3.  Despite the 
overlapping with CD signals, which prevented the quantification of CH2NCS resonance 
intensity decrease, the larger splitting of the methyl signal resulted a good alternative in 
these cases (Figure 5).  
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Figure 6. Section of the 1H NMR spectra of 4-RS complexes (500 MHz, 3 mM, D2O, 
1:3 molar ratio ) with αCD (A and B) or HPβCD (C and D) at time 0 (A and C) and 
after 4.5 months (b and D) at room temperature. The inbox highlights the CH3 signal 
splitting upon degradation (ca. 16% and 36% in 4.5 months for αCD and HPβCD, 
respectively). 
The integrity of the analogue was monitored for a similar period of time (4.5 months), 
after which degradation proved to be much slower: approximately 16% and 36% for the 
- and HPβCD formulations, respectively, as determined by separate integration of the 
splitted methyl signals. This result is in agreement with the lower concentration of 
unprotected (CD-uncomplexed) 4-RS in the equilibrium estimated in ca. 10% and 40%, 
respectively for α- and HPβCD according to the measured Kas (Table 1). This 
observation is further supported by the overall intensity increase of signal in the range 
2.95-2.80 ppm attributed to N-linked methylene groups arising from isothiocyanate 
degradation into amine and ulterior thiourea formation (Figure 5B and D). 
 
CONCLUSIONS 
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 In summary, we have reported in this study the first comparative study on the 
strength of the inclusion complexes of SFN and SFN homologues with different 
cyclodextrin by NMR spectroscopy. From this study it has been shown that despite of 
being widely used in the stabilisation of sulforaphane, HP--CD is the least indicated 
guest for this process as it form the inclusion complex with SFN homologue 4-RS with 
the lesser stability, being -CD the most indicated cyclodextrin. The study of inclusion 
complexes of -CD with natural SFN and natural SFN homologues shows that the 
highest affinity constant is that of the compound with the lengest aliphatic chain 
between the sulfinyl and isothiocyanate groups, ie RS-1-isothiocyanato-6-
(methylsulfinyl)hexane 4-RS, an important isothiocyanate obtained from the wasabi. 
The study of the inclusion complexes of -CD and the non-natural SFN and analogues 
with S absolute configuration at sulfur shows for the first time that -CD is able 
discriminate between the two enantiomers, with the natural R enantiomers forming the 
inclusion complexes with higher affinity. Based on the obtained experimental results, an 
explanative model on the topology of the inclusion complexes of isothiocyanates and -
CD as well as on the stereospecificity observed has been proposed.  The NMR study on 
the aqueous stabilization of isothiocyaate by cyclodextrins, confirms the titration studies 
and shows that the protecting capacity of the cyclodextrins as hosts is directly related to 
the stability of the inclusion complex with isothiocyanates guests, being -CD having 
the smallest internal hydrophobic cavity the better host. 
 
 
EXPERIMENTAL SECTION 
General experimental methods.  
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1H (and 13C NMR) spectra were recorded at 500 (125.7) with a Bruker Avance 
DRX500. 2D COSY and HMQC experiments were used to assist on NMR 
assignments. Chemical shifts are reported in ppm, and coupling constants are 
reported in Hz. Routine spectra were referenced to the residual proton or carbon 
signals of the solvent. High-resolution mass spectra were recorded on a Kratos 
MS-80RFA 241-MC apparatus. Optical rotations were measured at 20 ºC in a 1-
dm glass tube. -, -, and HP--CDs were purchased from Aldrich and used 
without purification. SFN 2-RS, isothiocyanates 3-RS and 4-RS as well as their 
enantiomers 2-SS, 3-SS and 4-SS used in this study were obtained following the 
recently reported enantiodivergent method based on the DAG-methodology. 
(-)-(R)-1-Isothiocyanate-4-(butylsulfinyl)butane (2-RS).  
 Colourless liquid. Rf = 0.15 (EtOAc / MeOH, 9:1); [α]D = -80.81 (c = 1.0 , 
CHCl3); 
1H NMR (500 MHz, CDCl3) δ 3.59 (t, 2H, J = 6.0Hz), 2.76-2.62 (m, 
4H), 1.98-1.82 (m, 4H), 1.79-1.72 (m, 2H), 1.56-1.43 (m, 2H), 0.98 (t, 3H, J = 
7.3 Hz); 13C NMR (125 MHz, CDCl3) δ 52.4, 51.3, 44.7, 29.1, 24.6, 22.1, 20.2, 
13.7; HRMS m/e calcd. for C9H17NONaS2 (M+Na)
+ : 242.0649, found: 242.0654. 
(+)-(S)-1Iisothiocyanate-4-(methylsulfinyl)butane (2-SS).  
Colourless liquid. Rf = 0.30 (EtOAc / MeOH, 9:1); [α]D = + 80.00 (c = 0.8, 
CHCl3); Spectroscopical data identical to those of the 2-RS enantiomer. HRMS 
m/e calcd. for C6H12NOS2 (M+H)
+: 178.0360, found: 178.0358.  
(-)-(R)-1-Isothiocyanate-5-(methylsulfinyl)pentane (4-RS). 
  Ambar syrup. Rf = 0.25 (EtOAc / MeOH, 9:1); [α]D = - 73.48 (c = 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 3.54 (t, 2H, J = 6.5 Hz), 2.76-2.63 (m, 2H), 2.57 
(s, 3H), 1.86-1.73 (m, 4H), 1.67-1.55 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 
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54.2, 44.7, 38.7, 29.6, 25.8, 21.9; HRMS m/e calcd. for C7H13NONaS2 (M+Na)
+: 
214.0336, found: 214.0339.  
(+)-(S)-1-Isothiocyanate-5-(methylsulfinyl)pentane (4-SS).  
 Ambar syrup. The spectroscopic data are identical to those of its enantiomer, 
4-RS. [α]D = + 69.23 (c = 0.8, CHCl3); HRMS m/e calcd. for C7H14NOS2 (M+H)+: 
192.0517, found: 192.0515. 
(R)-(-)-1-Isothiocyanato-6-(methylsulfinyl)hexane (5-RS). 
  Ambar syrup. Rf = 0.4 (EtOAc / MeOH, 9:1); [α]D = - 70.62 (c = 0.5, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 3.52 (t, 2H, J = 10.5 Hz), 2.77-2.60 (m, 2H), 2.56 
(s, 3H), 1.83-1.67 (m, 4H), 1.53-1.46 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 
54.4, 44.9, 38.7, 29.6, 27.9, 26.2, 22.4; HRMS m/e calcd. for C8H16NOS2 
(M+H)+: 206.0673, found: 206.0669.  
(+)-(S)-1-Isothiocyanate-6-(methylsulfinyl)hexane (5-SS). 
  Ambar syrup. The spectroscopic data are identical to those of its enantiomer, 
5-RS. [α]D = + 68.77 (c = 1.0, CHCl3); HRMS m/e calcd. for C8H16NOS2 (M+H)+: 
206.0673, found: 206.0677. 
NMR Titration Experiments. The association constants (Ka) were determined in 
D2O at 298 K on a 500 MHz by measuring the proton chemical shift changes of 
solutions of the SFN and SFN analogues 2-4 upon increasing amounts of host (-
CD, -CD, or HP--CD). In a typical titration experiment, a 3 mM solution of 4-
RS in D2O was prepared, a 500-μL aliquot was transferred to a 5-mm NMR tube, 
and the initial NMR spectrum was recorded. A 21 mM solution of -CD in the 
previous host solution was prepared and then sequentially added to the NMR tube 
containing the guest via microsyringe in 10 μL portions. These amounts were 
increased until 90-100% complexation of the host. The 1H NMR spectrum of 
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each mixture was recorded after each addition and the chemical shift of the 
diagnostic signals obtained at 15-19 different host-guest concentration ratios were 
used in an iterative least-squares fitting procedure (Bisson, Hunter, Morales, & 
Young, 1998; Bisson et al., 2000). 
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